Cargando…

Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model

OBJECTIVE: To assess the cost-effectiveness of cardiac resynchronisation therapy (CRT) both with CRT-P (biventricular pacemaker only) and with CRT-D (biventricular pacemaker with defibrillator) in patients with New York Heart Association (NYHA) functional class III/IV from a Belgian healthcare-payer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neyt, Mattias, Stroobandt, Serge, Obyn, Caroline, Camberlin, Cécile, Devriese, Stephan, De Laet, Chris, Van Brabandt, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2011
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3211050/ https://www.ncbi.nlm.nih.gov/pubmed/22021894 http://dx.doi.org/10.1136/bmjopen-2011-000276

Ejemplares similares

A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population
por: Neyt, Mattias, et al.
Publicado: (2012)

First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis
por: Neyt, Mattias, et al.
Publicado: (2018)

The cost-utility of catheter ablation of atrial fibrillation: a systematic review and critical appraisal of economic evaluations
por: Neyt, Mattias, et al.
Publicado: (2013)

Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
por: Neyt, Mattias, et al.
Publicado: (2014)

Safety of percutaneous aortic valve insertion. A systematic review
por: Van Brabandt, Hans, et al.
Publicado: (2009)

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions
por: Neyt, Mattias, et al.
Publicado: (2010)

Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure
por: Gao, Lan, et al.
Publicado: (2019)

Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits – a Markov model-based simulation study
por: Nguyen, Dieu, et al.
Publicado: (2023)

Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator
por: Hadwiger, Moritz, et al.
Publicado: (2020)

Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
por: Mistry, Hema, et al.
Publicado: (2012)

Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study
por: Han, Mingyang, et al.
Publicado: (2022)

Cost effectiveness of screening for intracranial aneurysms among patients with bicuspid aortic valve: a Markov modelling study
por: Chen, Jigang, et al.
Publicado: (2021)

Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model
por: Sun, Chengyao, et al.
Publicado: (2021)

Age of cardiac resynchronisation therapy; cardiac resynchronisation therapy in elderly
por: Cerit, Levent
Publicado: (2016)

Cardiac resynchronisation improves survival in mild heart failure!
por: van der Wall, E. E.
Publicado: (2011)

In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain models
por: Shine, Brian, et al.
Publicado: (2019)

Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models
por: Moriarty, Frank, et al.
Publicado: (2019)

Economic evaluation of a dedicated cardiac resynchronisation therapy preassessment clinic
por: Sidhu, Baldeep Singh, et al.
Publicado: (2020)

Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective
por: Ni, Weiyi, et al.
Publicado: (2020)

Cost-effectiveness of milk powder fortified with potassium to decrease blood pressure and prevent cardiovascular events among the adult population in China: a Markov model
por: Dainelli, Livia, et al.
Publicado: (2017)

Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199
por: Stroobandt, Serge, et al.
Publicado: (2021)

Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model
por: Delgleize, Emmanuelle, et al.
Publicado: (2016)

Cost-effectiveness analysis of different screening strategies for colorectal cancer in Guangzhou, southern China: a Markov simulation analysis based on natural community screening results
por: Zhou, Qin, et al.
Publicado: (2021)

Is Cardiac Resynchronisation Therapy Proarrhythmic?
por: Leyva, Francisco, et al.
Publicado: (2008)

Gender in cardiac resynchronisation therapy
por: Enina, Tatiana N., et al.
Publicado: (2018)

Improving Cardiac Resynchronisation Therapy
por: Thomas, George, et al.
Publicado: (2019)

Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
por: Redding, Stuart, et al.
Publicado: (2023)

Current aspects of cardiac resynchronisation therapy
por: Meine, M., et al.
Publicado: (2015)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Cardiac resynchronisation therapy in optima forma
por: Timmer, S. A. J., et al.
Publicado: (2022)

Conduction System Pacing for Cardiac Resynchronisation
por: Sharma, Parikshit S, et al.
Publicado: (2021)

Cardiac Resynchronisation with Conduction System Pacing
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Managing arrhythmia in cardiac resynchronisation therapy
por: de Vere, Felicity, et al.
Publicado: (2023)

Progress in Cardiac Resynchronisation Therapy and Optimisation
por: Akhtar, Zaki, et al.
Publicado: (2023)

Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial
por: Vestergaard, Anne Sig, et al.
Publicado: (2020)

Cost-effectiveness analysis of cinacalcet for haemodialysis patients with moderate-to-severe secondary hyperparathyroidism in China: evaluation based on the EVOLVE trial
por: Liu, Lin, et al.
Publicado: (2020)

Echocardiography and cardiac resynchronisation therapy, friends or foes?
por: van Everdingen, W.M., et al.
Publicado: (2015)

Optimisation of cardiac resynchronisation therapy during exercise
por: Ghani, A., et al.
Publicado: (2013)

Resynchronisation as an Element of Improving Cattle Reproduction Efficiency
por: Jaśkowski, Jędrzej M., et al.
Publicado: (2019)

Effect of cardiac resynchronisation therapy in dilated cardiomyopathy
por: Bouwmeester, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ektr93qap62u3es0p6lptt39e6